(Update) Report on Symposium “Global Health and Corporate Strategy: Varied and Innovative Models”
date : 12/25/2012
The symposium “Global Health and Corporate Strategy: Varied and Innovative Models” was hosted in collaboration with the GAVI Alliance and UNICEF Tokyo Office.
With
the IMF/World Bank annual general meetings was held in Tokyo in October,
attention was drawn toward the major agenda of investments into health. Under
this increased momentum, the emphasis at this symposium was on partnerships
within corporations and various organizations particularly for the solving of
global health problems. The merits, barriers and solutions to such partnerships
was discussed through the sharing of successful examples, and with a focus on
the impact produced by international social action that utilized the special
features of businesses and varied and innovative approaches it was aspired to
help solve global health problems.
(Please download our report, program and questionnaire from the right )
(You can see some parts of videos on the day from here (YouTube).)
GAVI – HGPI – UNICEF Collaborative Symposium
“Global Health and Corporate Strategy: Diverse, Innovative Partnership Models”
■Date : Thursday, October 11, 2012 from 15:00~18:00
■Venue : Fujifilm
Corporation / Midtown West Conference room (2F)
■Co-organizers: GAVI Alliance/ Health and Global Policy Institute (HGPI)/
UNICEF Tokyo Office
■Supported by the
Ministry of Foreign Affairs of Japan
■In cooperation with : RESULTS Japan
■Program
1. Opening Remarks(15:00-15:10)
– Dr. Seth Berkley (CEO, GAVI Alliance)
2. Keynote Speeches
Keynote Speeches 1(15:10-15:40)
–
Dr. Kiyoshi Kurokawa (Chairman, HGPI)
Keynote Speeches 2(15min.)
–
Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
Break (15:40-16:00)
3. Panel Discussion: Multi-Stakeholder Partnerships in Global
Health(16:00-17:40)
Moderator: Mr. Koichi Kaneda (Senior Director, Corporate Social
Responsibility, Corporate Communication, Takeda Pharmaceutical Company Limited)
1) “Partnership Case Study –Ghana Project–”
– Dr. Yasuhiko Toride, Director of Nutrition Improvement
Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co.,
Inc.
2) “Partnership Case Study –Anti-Infective Drug–”
– Dr. Junichi Mitsuyama, Senior Operations Manager, FUJIFILM
Corporation / Director, Toyama Chemical Co., Ltd.
3) “Partnership Case Study –Vaccine &
Medicine Development for NTDs through Partnership–“
– Dr.
BT Slingsby (Director of Global Access Strategies,
Eisai Co., Ltd.)
4) “Partnership Case Study –Vaccine Bonds–”
– Mr. Satoru Yamamoto, Director, Head of International
Investors Services, FICC Sales Dept (I), Daiwa Securities
5) “Promoting Global Partnership for
Children–Case Studies and Considerations–”
– Dr. Kunihiko Chris Hirabayashi (Director, United Nations Children’s Fund Tokyo office)
Discussion (50 min)
4. Wrap-up(17:40-17:55)
– Dr. Seth Berkley (CEO, GAVI Alliance)
– Dr. Dr. Tadataka Yamada(Member of the Board, Chief Medical & Scientific
Officer, Takeda Pharmaceutical Company Limited)
– Dr. Kiyoshi Kurokawa (Chairman, HGPI)
5. Closing Remarks
– Dr.
Shiro Konuma (Director, Global Health Policy Division International Cooperation Bureau
Ministry of Foreign Affairs)(17:55-18:00)
Contact Details:
GAVI – HGPI – UNICEF Collaborative Symposium Japan Secretariat
Health and Global Policy Institute
1-11-28 Nagatacho,Chiyoda-Ku Tokyo 100-0014 Japan
E-mail: symposium1011@hgpi.org
Normal 0 0 2 false false false EN-US JA X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:標準の表; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0mm 5.4pt 0mm 5.4pt; mso-para-margin:0mm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.5pt; mso-bidi-font-size:11.0pt; font-family:”Century”,”serif”; mso-ascii-font-family:Century; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Century; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt;}
Registration deadline: 2012-10-09
Exhibition date:2012-10-11
Top Research & Recommendations Posts
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Announcement] Signs “A COP29 for People and Planet: Recommendations from the international health and climate community” (November 11, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Discussion Points] Women’s Health Project Expert Meeting “The Ideal System for Perinatal Medical Care in Japan in the Era of Declining Birth Rates” (November 11, 2024)
Featured Posts
-
2024-11-21
[Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-01
[Activity Report] Announcing the Launch of the Japan’s Patient Expert Platform (J-PEP) Website (December 1, 2024)